Search for Clinical Trial Results
Cholangitis - 111 Studies Found
Status | Study |
Recruiting |
Study Name: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-01-08 Interventions: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
Withdrawn |
Study Name: The Value of CT Cholangiography in Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2007-12-26 Interventions: Procedure: CT cholangiography Cholografin 20ml will be diluted in 100 ml of normal saline and infused ov |
Completed |
Study Name: Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-03-11 |
Recruiting |
Study Name: Swiss Primary Sclerosing Cholangitis Cohort Study Condition: Cholangitis, Sclerosing Date: 2017-05-08 |
Completed |
Study Name: Trial of High-dose Urso in Primary Sclerosing Cholangitis Condition: Sclerosing Cholangitis Date: 2003-04-21 Interventions: Drug: Ursodeoxycholic Acid |
Recruiting |
Study Name: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis (PBC) Date: 2017-03-28 Interventions:
|
Completed |
Study Name: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2010-03-12 Interventions: Drug: ursodeoxycholic acid (UDCA) Pediatric PSC patients already receiving UDCA therapy will enter a fou |
Recruiting |
Study Name: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2014-09-04 Interventions: Drug: BTT1023 IV (in the vein) Investigational Medicinal Product (IMP) |
Recruiting |
Study Name: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis Date: 2017-03-24 Interventions:
|
Not yet recruiting |
Study Name: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis Condition: Primary Biliary Cholangitis Date: 2017-05-11 Interventions: Drug: APD334 APD334 active treatment for 24 weeks. O |